These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7685764)

  • 61. Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes.
    Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
    J Neurochem; 2001 Feb; 76(3):901-9. PubMed ID: 11158262
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Site-directed and deletion mutational analysis of the receptor binding domain of the interleukin-6 receptor targeted fusion toxin DAB389-IL-6.
    Jean LF; Waters CA; Keemy D; Murphy JR
    Protein Eng; 1993 Apr; 6(3):305-11. PubMed ID: 8506265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.
    Nishimura C; Watanabe A; Gouda H; Shimada I; Arata Y
    Biochemistry; 1996 Jan; 35(1):273-81. PubMed ID: 8555185
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
    Jerva LF; Sullivan G; Lolis E
    Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-1 beta-specific partial agonists defined by site-directed mutagenesis studies.
    Guinet F; Guitton JD; Gault N; Folliard F; Touchet N; Cherel JM; Crespo A; Destourbe A; Bertrand P; Denefle P
    Eur J Biochem; 1993 Feb; 211(3):583-90. PubMed ID: 8436117
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts.
    Penton-Rol G; Orlando S; Polentarutti N; Bernasconi S; Muzio M; Introna M; Mantovani A
    J Immunol; 1999 Mar; 162(5):2931-8. PubMed ID: 10072543
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor.
    Kalai M; Montero-Julian FA; Grötzinger J; Wollmer A; Morelle D; Brochier J; Rose-John S; Heinrich PC; Brailly H; Content J
    Eur J Biochem; 1996 Jun; 238(3):714-23. PubMed ID: 8706672
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor.
    Burstein ES; Spalding TA; Brann MR
    Biochemistry; 1998 Mar; 37(12):4052-8. PubMed ID: 9521726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor.
    Wessendorf JH; Garfinkel S; Zhan X; Brown S; Maciag T
    J Biol Chem; 1993 Oct; 268(29):22100-4. PubMed ID: 8408068
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of IL-1β and two types of IL-1 receptors in miiuy croaker and evolution analysis of IL-1 family.
    Yang Q; Chu Q; Zhao X; Xu T
    Fish Shellfish Immunol; 2017 Apr; 63():165-172. PubMed ID: 28189765
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [In vitro and in vivo study of regulation mechanisms of type I interleukin-1 receptor].
    Takii T
    Yakugaku Zasshi; 2001 Jan; 121(1):9-21. PubMed ID: 11201166
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
    Li C; Zienkiewicz J; Hawiger J
    J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Active center cleft residues of pokeweed antiviral protein mediate its high-affinity binding to the ribosomal protein L3.
    Rajamohan F; Ozer Z; Mao C; Uckun FM
    Biochemistry; 2001 Aug; 40(31):9104-14. PubMed ID: 11478877
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Involvement of the Arg179 in the active site of human IL-6.
    Fontaine V; Savino R; Arcone R; de Wit L; Brakenhoff JP; Content J; Ciliberto G
    Eur J Biochem; 1993 Feb; 211(3):749-55. PubMed ID: 8436132
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding.
    Cui X; Rouhani FN; Hawari F; Levine SJ
    J Immunol; 2003 Dec; 171(12):6814-9. PubMed ID: 14662887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction.
    Tada M; Diserens AC; Desbaillets I; de Tribolet N
    J Neurosurg; 1994 Jun; 80(6):1063-73. PubMed ID: 7514661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defining the structural requirements of a biologically active domain of human IL-1 beta.
    Boraschi D; Antoni G; Perin F; Villa L; Nencioni L; Ghiara P; Presentini R; Tagliabue A
    Eur Cytokine Netw; 1990; 1(1):21-6. PubMed ID: 2102359
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.
    Bossù P; Visconti U; Ruggiero P; Macchia G; Muda M; Bertini R; Bizzarri C; Colagrande A; Sabbatini V; Maurizi G
    Am J Pathol; 1995 Dec; 147(6):1852-61. PubMed ID: 7495308
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.
    Touzani O; Boutin H; LeFeuvre R; Parker L; Miller A; Luheshi G; Rothwell N
    J Neurosci; 2002 Jan; 22(1):38-43. PubMed ID: 11756486
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR; Matsunami RK; Engler DA; Niyogi SK
    Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.